Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement

MLA

Paola Cravero, et al. “Impressive Clinical Response to Anti-PD-1 Therapy in Epithelioid Mesothelioma with High Clonal PD-L1 Expression and EML4-ALK Rearrangement.” Lung Cancer, vol. 142, Apr. 2020, pp. 47–50. EBSCOhost, https://doi.org/10.1016/j.lungcan.2020.02.006.

APA

Paola Cravero, Marco Angelo Burgio, Danila Diano, Angelo Delmonte, Sara Bravaccini, Lucio Crinò, Giovanni Martinelli, Maurizio Puccetti, Paola Ulivi, Giulio Rossi, Alberto Verlicchi, Maria Maddalena Tumedei, & Giuseppe Bronte. (2020). Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement. Lung Cancer, 142, 47–50. https://doi.org/10.1016/j.lungcan.2020.02.006

Chicago

Paola Cravero, Marco Angelo Burgio, Danila Diano, Angelo Delmonte, Sara Bravaccini, Lucio Crinò, Giovanni Martinelli, et al. 2020. “Impressive Clinical Response to Anti-PD-1 Therapy in Epithelioid Mesothelioma with High Clonal PD-L1 Expression and EML4-ALK Rearrangement.” Lung Cancer 142 (April): 47–50. doi:10.1016/j.lungcan.2020.02.006.